Pharmaceuticals & Therapeutics

A parent-led company gains a U.S. patent for a diazoxide formulation, offering new hope for managing behavioral symptoms in Prader-Willi syndrome.

At a major oncology conference, Zephyr AI will showcase AI that predicts patient response to targeted therapies, aiming to personalize cancer treatment.

A new strategic deal for the Lasix ONYU device aims to secure its key ingredient, transforming heart failure care from the hospital to the living room.

Following a major partnership, AST and Marchesini Group will showcase next-gen robotic filling and inspection tech, aiming to reshape sterile drug production.

With new top-tier executives, Danish biotech MinervaX is accelerating its quest to deliver the world's first vaccine against a leading cause of infant death.

As millions drive on common medications, a leading expert joins a national panel to address the silent, growing crisis on America's roadways.

A proposed $108.5M FDA funding boost aims to modernize infant formula rules, paving the way for plant-based options and a more secure supply chain.

Phase 3 data shows GTx-104 reduces key risks and improves outcomes for aSAH patients, positioning it as a potential new standard of care ahead of an FDA decision.

Oxford spinout Caristo Diagnostics appoints Stephen Deitsch, who led a $1.5B exit, as CEO to accelerate its mission of preventing heart attacks with AI.

Taiwanese biotech GlycoNex will begin human trials for GNX1021, a novel ADC that targets cancer's unique sugar coating to fight GI tumors.

The Swiss medtech firm reports a massive Q1 sales jump, backed by strong clinical data and a strategic US manufacturing expansion to meet surging demand.

A new report reveals a major gap in AI adoption as digital disruptors and generic GLP-1s force Canadian pharmacies to innovate or risk being left behind.

European non-profit ELRIG launches its first US conference, a free-to-attend event aiming to connect scientists and tackle intractable drug targets.

Display giant HKC is leveraging its ANTGAMER brand to challenge the esports market with world-first refresh rates and a bold global expansion strategy.

A global partnership aims to bring Atla-cel, a next-gen CAR-T therapy with low neurotoxicity, to children with leukaemia, potentially revolutionizing treatment.

Velo Med Spa introduces a revolutionary non-surgical body contouring solution using donor-derived tissue, promising natural results without the knife.

A novel drug combination shows promising early results for a deadly ovarian cancer, potentially expanding the benefit of immunotherapy to more patients.

A new alliance aims to deliver nine vital rare disease therapies to Africa, tackling one of global health's most profound access challenges.

ANI Pharmaceuticals launches a generic version of Carbatrol, aiming for a slice of a $65M market and promising improved patient access for chronic conditions.

With youth melanoma a growing concern, a new curriculum gives teens free, classroom-ready tools to build lifelong sun safety habits and reduce their risk.